Sugi Predict

Sugi Predict / Compounds / SCHEMBL693879

SCHEMBL693879

SCHEMBL693879

COc1ccc2c(C)[c]oc2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 9/20 0.47
▸ ALDH1A1 P00352 9/20 0.47
▸ HPGD P15428 4/20 0.47
▸ HSD17B10 Q99714 3/20 0.47
▸ MAPT P10636 4/20 0.45
▸ NPC1 O15118 3/20 0.45
▸ RAB9A P51151 3/20 0.45
▸ POLB P06746 1/20 0.45
▸ STAT1 P42224 1/20 0.45
▸ GAA P10253 1/20 0.44
▸ MAOB P27338 4/20 0.43
▸ MAOA P21397 1/20 0.42
▸ LMNA P02545 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ PIN1 Q13526 1/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ CASP3 P42574 1/20 0.41
▸ SENP8 Q96LD8 1/20 0.41
▸ SENP7 Q9BQF6 1/20 0.41
▸ SENP6 Q9GZR1 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3532152 0.85 ALDH1A1 (0.49) KDM4EALDH1A1HPGDHSD17B10MAPT
SCHEMBL4034664 0.76 MAOB (0.38) KDM4EALDH1A1HPGDHSD17B10MAPT
SCHEMBL3100971 0.73 MAPT (0.35) ALDH1A1HPGDMAPTNPC1RAB9A
SCHEMBL3949954 0.73 MAOB (0.39) MAOB
SCHEMBL7097279 0.71 KDM4E (0.69) KDM4EALDH1A1HPGDHSD17B10MAPT
SCHEMBL23728240 0.70 KDM4E (0.57) KDM4EALDH1A1HPGDHSD17B10MAPT
SCHEMBL22106289 0.68 MAOB (0.59) KDM4EALDH1A1HPGDHSD17B10MAPT
SCHEMBL31299896 0.68 PIN1 (0.58) KDM4EALDH1A1HPGDHSD17B10MAPT
SCHEMBL10171847 0.68 PIN1 (0.58) KDM4EALDH1A1HPGDHSD17B10MAPT
SCHEMBL8074385 0.68 MAPT (0.63) KDM4EALDH1A1HPGDHSD17B10MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8962607-B2 Azetidinyl diamides as monoacylglycerol lipase inhibitors JANSSEN PHARMACEUTICA NV (BE) 2015-02-24 — — US claimed
EP-2421823-B1 AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2015-01-14 — — EP claimed
US-20140243305-A1 AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS JANSSEN PHARMACEUTICA NV (US) 2014-08-28 — — US claimed
US-8445477-B2 Azetidinyl diamides as monoacylglycerol lipase inhibitors JANSSEN PHARMACEUTICA, NV (BE) 2013-05-21 — — US claimed
EP-2421823-A1 AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS Janssen Pharmaceutica N.V. (BE) 2012-02-29 — — EP claimed
US-20100324012-A1 AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2010-12-23 — — US claimed
WO-2010124086-A1 AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2010-10-28 — — WO claimed
EP-1307204-A4 PROTEASE INHIBITORS SMITHKLINE BEECHAM CORP (US) 2004-06-02 — — EP claimed
EP-1392657-A4 PROTEASE INHIBITORS SMITHKLINE BEECHAM CORP (US) 2004-03-10 — — EP claimed
EP-1392657-A2 PROTEASE INHIBITORS SmithKline Beecham Corporation (US) 2004-03-03 — — EP claimed
US-20040038965-A1 Protease inhibitors SMITHKLINE BEECHAM CORPORATION 2004-02-26 — — US claimed
US-20040002487-A1 Protease inhibitors MARQUIS ROBERT WELLS (US) 2004-01-01 — — US claimed
US-20030225061-A1 Protease inhibitors MARQUIS ROBERT WELLS (US) 2003-12-04 — — US claimed
US-20030144175-A1 Protease inhibitors SMITHKLINE BEECHAM CORPORATION 2003-07-31 — — US claimed
WO-2003053331-A2 PROTEASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2003-07-03 — — WO claimed
EP-1307204-A1 PROTEASE INHIBITORS SmithKline Beecham Corporation (US) 2003-05-07 — — EP claimed
US-20020147188-A1 Protease inhibitors SMITHKLINE BEECHAM CORPORATION 2002-10-10 — — US claimed
WO-2001095911-A1 PROTEASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2001-12-20 — — WO claimed
US-8962607-B2 Azetidinyl diamides as monoacylglycerol lipase inhibitors JANSSEN PHARMACEUTICA NV (BE) 2015-02-24 — — US disclosed
WO-2001095911-A1 PROTEASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2001-12-20 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040038965-A1 Protease inhibitors CTSK, CTSZ, CTSE KDM4E 1836/4885ALDH1A1 3561/4885HPGD 884/4885
US-20030225061-A1 Protease inhibitors CTSK, MMP13, CTSZ KDM4E 917/4885ALDH1A1 3651/4885HPGD 471/4885
US-20140243305-A1 AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS PNLIP, LPL, LIPA KDM4E 1931/4885ALDH1A1 364/4885HPGD 731/4885
US-20020147188-A1 Protease inhibitors CTSK, MMP13, CTSZ KDM4E 917/4885ALDH1A1 3651/4885HPGD 471/4885
US-20100324012-A1 AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS PNLIP, LPL, LIPA KDM4E 1931/4885ALDH1A1 364/4885HPGD 731/4885
US-20040002487-A1 Protease inhibitors CTSK, MMP13, CTSZ KDM4E 917/4885ALDH1A1 3651/4885HPGD 471/4885
US-20030144175-A1 Protease inhibitors CTSK, MMP13, CTSZ KDM4E 917/4885ALDH1A1 3651/4885HPGD 471/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.